Liability disclaimer: UK SARMs is not responsible for any adverse effects experienced as a result of using this product
SURMOUNT-3: Tirzepatide adds substantial weight loss after lifestyle intervention Following a 12-week intensive lifestyle intervention, tirzepatide continued to deliver significant additional weight loss versus placebo over 72 weeks, with large mean body-weight reductions and high rates of 5% weight loss
Those factors could help explain the benefits seen in heart failure patients, cardiologist Barry Borlaug reported at the meeting and in Nature Medicine
These include increased heart rate and changes in heart rhythm, which could potentially lead to AFib
doi: 10.1002/oby.24336
Consumers are increasingly looking for: Smaller portions Higher protein More fiber Greater nutrient density Convenient, grab-and-go formats That likely means new SKUs, refreshed brands, variety packs, trial programs, club configurations, and promotional launchesall before companies know exactly what will stick in the market